NCT00299611 - Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG

Sertraline

Tablets, 50mg each, (1-3TABLETS/DAY) during the Open-label phase for first 8 wks.

DRUG

Levetiracetam

Tablets, dosage 500mg each tablet (1-4tablets/day)for 8 wks during the 2nd phase of the study.

DRUG

Placebo

Tablets, No active ingredient, (1-4tablets/day) for 8 wks during the 2nd phase of the study.

Trial Locations (1)

Duke University Medical Center, Durham